NEW
YORK, April 23, 2024 /PRNewswire/ -- The
global ursodeoxycholic acid market size is
estimated to grow by USD 358.41
million from 2023-2027, according to Technavio. The market is
estimated to grow at a CAGR of 10.65% during the
forecast period. Liver diseases, including cirrhosis and liver
cancer, contribute to a staggering two million deaths annually
worldwide. The surge in liver transplants reflects the pressing
need for effective treatments. UDCA emerges as a vital solution,
driving its market growth.
For more insights on the forecast market size and
historic data (2017 - 2021) - Buy Report
Awareness Spurs Demand
Awareness about the mortality rates associated with liver
diseases is on the rise. People are increasingly cognizant of the
detrimental effects of chronic liver ailments, fueling demand for
treatments like UDCA. This growing awareness among the populace is
a significant driver for market expansion.
Prevalence of Liver Diseases
The prevalence of liver diseases is on an upward trajectory,
further propelling the demand for UDCA. Factors such as hepatitis
infections, excessive alcohol consumption, and various
liver-related disorders contribute to this trend. UDCA's efficacy
in managing these conditions positions it as a sought-after
therapeutic option.
Forecast for Market Growth
With the increasing demand for UDCA treatments, the market is
poised for substantial growth in the forecast period. The
convergence of factors such as rising liver transplants, heightened
awareness about liver health, and the prevalence of liver diseases
sets a promising trajectory for the UDCA market.
For inputs on more Market Drivers, trends, &
Challenges- Request a sample report!
Research Analysis
The Ursodeoxycholic Acid (UDCA) market encompasses branded and
generic versions of this essential bile acid used in the treatment
of various liver disorders, including Primary Biliary Cholangitis
(PBC) and Primary Biliary Cirrhosis (PBC-PBC). UDCA plays a crucial
role in improving liver function by reducing inflammation and
promoting the flow of bile. Patients with conditions such as
cholestasis, gastroesophageal varices, and cirrhosis can benefit
from UDCA-based therapies. Pharmacies and healthcare providers
offer oral therapies containing UDCA, which can be found in both
branded and generic forms. These products are essential for
managing liver health and alleviating symptoms associated with
liver disorders. UDCA's unique properties, such as its ability to
bind with hydrophobic bile acids, make it a valuable component in
the treatment of liver diseases. Advancements in biotechnology and
nanotechnology have led to the development of innovative UDCA-based
therapies, providing patients with improved strengths and efficacy.
Taurine, a natural amino acid, is often used in combination with
UDCA to enhance its therapeutic effects. The Ursodeoxycholic Acid
market continues to grow as more patients and healthcare providers
recognize its importance in managing liver disorders.
Market Research Overview
The Ursodeoxycholic Acid market is a significant segment in
the pharmaceutical industry, focusing on the production and
distribution of this bile acid. Primarily used in the treatment of
gallstones and other liver diseases, Ursodeoxycholic Acid is a
cholesteric and a hydrophilic bile acid. Its primary functions
include promoting the dissolution of cholesterol gallstones,
improving bile flow, and aiding in the emulsification of dietary
fats. The global market for Ursodeoxycholic Acid is driven by the
increasing prevalence of liver diseases and gallstones worldwide.
Major players in this market include Branded Generics, Specialty
Pharmaceuticals, and Niche Players. The market is expected to grow
steadily due to the rising demand for effective treatments for
liver-related conditions. Additionally, the development of new
formulations and delivery systems is expected to further fuel
market growth. Overall, the Ursodeoxycholic Acid market holds
immense potential for innovation and growth in the healthcare
sector.
For inputs on more Market Drivers, trends, &
Challenges- Request a sample report!
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ursodeoxycholic-acid-market-size-is-set-to-grow-by-usd-358-41-million-from-2023-2027--rise-in-number-of-liver-transplants-boost-the-market-technavio-302123319.html
SOURCE Technavio